| Advantage Hospice Providers, Inc 600 N Mountain Avenue, Suite B201, Upland, CA, 91786 | |
| (909) 296-7903 |
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| Name | Advantage Hospice Providers, Inc |
|---|---|
| Location | 600 N Mountain Avenue, Suite B201, Upland, California |
| Hospice ID | 751556 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 460 |
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| NPI Number | 1699109306 |
| Organization Name | Advantage Hospice Providers Inc |
| Address | 600 N Mountain Ave Upland, California, 91786 |
| Phone Number | (909)296-7903 |
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| Home Health Aides | 1 |
| Counselors | 3 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 1 |
| Other Personnel | 1 |
| Total Employees | 9 |
|---|
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
A team of bioengineers at Rensselaer Polytechnic Institute, with funding from the National Institute of Biomedical Imaging and Bioengineering, have developed an artificial intelligence technique that uses image post-processing to rapidly convert low-dose computed tomography scans to images of superior quality, compared to low-dose scans that do not use the AI technique.
Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder.
Impel NeuroPharma, a medical device company developing a novel drug delivery device that enables drugs to bypass the blood-brain barrier (BBB) using direct nose-to-brain delivery, today announced a set of important milestones in its drive to commercialize its POD technology.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers - a blood clot - that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to myocardial infarction, ischemic stroke, and other cardiovascular diseases. How does fibrin manage to be so strong and yet so extensible under the stresses of healing and blood flow?
› Verified 3 days ago
| St Grace Hospice Inc Location: 904 West Ninth Street, Upland, California, 91786 Phone: (909) 296-7903 |
| Ghc Hospice Inc Location: 906 W 9th Street, Upland, California, 91786 Phone: (909) 296-7903 |
| A To Z Hospice Care Inc Location: 1202 Monte Vista Avenue Suite #4, Upland, California, 91786 Phone: (909) 296-7903 |
| Pandora Hospice Care Inc Location: 600 N Mountain Avenue Suite A201, Upland, California, 91786 Phone: (909) 296-7903 |